Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes

Preeti Kishore, Julia Tonelli, Sudha Koppaka, Corina Fratila, Anita Bose, Do Eun Lee, Kalpana Reddy, Meredith A. Hawkins

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Impaired effectiveness of glucose to suppress endogenous glucose production (EGP) is an important cause of worsening hyperglycemia in type 2 diabetes. Elevated free fatty acids (FFAs) may impair glucose effectiveness via several mechanisms, including rapid changes in metabolic fluxes and/or more gradual changes in gene expression of key enzymes or other proteins. Thus, we examined the magnitude and time course of effects of FFAs on glucose effectiveness in type 2 diabetes and whether glucose effectiveness can be restored by lowering FFAs. Glucose fluxes ([3-3H]-glucose) were measured during 6-h pancreatic clamp studies, at euglycemia (5 mmol/l glucose, t = 0-240 min), and hyperglycemia (10 mmol/l, t = 240-360 min). We studied 19 poorly controlled subjects with type 2 diabetes (HbA1c 10.9 ± 0.4%, age 50 ± 3 years, BMI 30 ± 2 kg/m2) on at least two occasions with saline (NA- group) or nicotinic acid (NA group) infusions for 3, 6, or 16 h (NA3h, NA6h, and NA16h groups, respectively) to lower FFAs to nondiabetic levels. As a reference group, glucose effectiveness was also assessed in 15 nondiabetic subjects. There was rapid improvement in hepatic glucose effectiveness following only 3 h of NA infusion (NA3h = 31 ± 6% suppression of EGP with hyperglycemia vs. NA- = 8 ± 7%; P < 0.01) and complete restoration of glucose effectiveness after 6 h of NA (NA6h = 41 ± 8% suppression of EGP; P = NS vs. nondiabetic subjects). Importantly, the loss of hepatic glucose effectiveness in type 2 diabetes is completely reversible upon correcting the increased FFA concentrations. A longer duration of FFA lowering may be required to overcome the chronic effects of increased FFAs on hepatic glucose effectiveness.

Original languageEnglish (US)
Pages (from-to)1761-1768
Number of pages8
JournalDiabetes
Volume55
Issue number6
DOIs
StatePublished - 2006

Fingerprint

Nonesterified Fatty Acids
Type 2 Diabetes Mellitus
Glucose
Hyperglycemia
Liver
Niacin

Keywords

  • EGP
  • Endogenous glucose production
  • FFA
  • Free fatty acid

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Kishore, P., Tonelli, J., Koppaka, S., Fratila, C., Bose, A., Lee, D. E., ... Hawkins, M. A. (2006). Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes. Diabetes, 55(6), 1761-1768. https://doi.org/10.2337/db05-0988

Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes. / Kishore, Preeti; Tonelli, Julia; Koppaka, Sudha; Fratila, Corina; Bose, Anita; Lee, Do Eun; Reddy, Kalpana; Hawkins, Meredith A.

In: Diabetes, Vol. 55, No. 6, 2006, p. 1761-1768.

Research output: Contribution to journalArticle

Kishore, P, Tonelli, J, Koppaka, S, Fratila, C, Bose, A, Lee, DE, Reddy, K & Hawkins, MA 2006, 'Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes', Diabetes, vol. 55, no. 6, pp. 1761-1768. https://doi.org/10.2337/db05-0988
Kishore P, Tonelli J, Koppaka S, Fratila C, Bose A, Lee DE et al. Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes. Diabetes. 2006;55(6):1761-1768. https://doi.org/10.2337/db05-0988
Kishore, Preeti ; Tonelli, Julia ; Koppaka, Sudha ; Fratila, Corina ; Bose, Anita ; Lee, Do Eun ; Reddy, Kalpana ; Hawkins, Meredith A. / Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes. In: Diabetes. 2006 ; Vol. 55, No. 6. pp. 1761-1768.
@article{9bdd3da5d5334fd9a99fc0f26abd96d9,
title = "Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes",
abstract = "Impaired effectiveness of glucose to suppress endogenous glucose production (EGP) is an important cause of worsening hyperglycemia in type 2 diabetes. Elevated free fatty acids (FFAs) may impair glucose effectiveness via several mechanisms, including rapid changes in metabolic fluxes and/or more gradual changes in gene expression of key enzymes or other proteins. Thus, we examined the magnitude and time course of effects of FFAs on glucose effectiveness in type 2 diabetes and whether glucose effectiveness can be restored by lowering FFAs. Glucose fluxes ([3-3H]-glucose) were measured during 6-h pancreatic clamp studies, at euglycemia (5 mmol/l glucose, t = 0-240 min), and hyperglycemia (10 mmol/l, t = 240-360 min). We studied 19 poorly controlled subjects with type 2 diabetes (HbA1c 10.9 ± 0.4{\%}, age 50 ± 3 years, BMI 30 ± 2 kg/m2) on at least two occasions with saline (NA- group) or nicotinic acid (NA group) infusions for 3, 6, or 16 h (NA3h, NA6h, and NA16h groups, respectively) to lower FFAs to nondiabetic levels. As a reference group, glucose effectiveness was also assessed in 15 nondiabetic subjects. There was rapid improvement in hepatic glucose effectiveness following only 3 h of NA infusion (NA3h = 31 ± 6{\%} suppression of EGP with hyperglycemia vs. NA- = 8 ± 7{\%}; P < 0.01) and complete restoration of glucose effectiveness after 6 h of NA (NA6h = 41 ± 8{\%} suppression of EGP; P = NS vs. nondiabetic subjects). Importantly, the loss of hepatic glucose effectiveness in type 2 diabetes is completely reversible upon correcting the increased FFA concentrations. A longer duration of FFA lowering may be required to overcome the chronic effects of increased FFAs on hepatic glucose effectiveness.",
keywords = "EGP, Endogenous glucose production, FFA, Free fatty acid",
author = "Preeti Kishore and Julia Tonelli and Sudha Koppaka and Corina Fratila and Anita Bose and Lee, {Do Eun} and Kalpana Reddy and Hawkins, {Meredith A.}",
year = "2006",
doi = "10.2337/db05-0988",
language = "English (US)",
volume = "55",
pages = "1761--1768",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes

AU - Kishore, Preeti

AU - Tonelli, Julia

AU - Koppaka, Sudha

AU - Fratila, Corina

AU - Bose, Anita

AU - Lee, Do Eun

AU - Reddy, Kalpana

AU - Hawkins, Meredith A.

PY - 2006

Y1 - 2006

N2 - Impaired effectiveness of glucose to suppress endogenous glucose production (EGP) is an important cause of worsening hyperglycemia in type 2 diabetes. Elevated free fatty acids (FFAs) may impair glucose effectiveness via several mechanisms, including rapid changes in metabolic fluxes and/or more gradual changes in gene expression of key enzymes or other proteins. Thus, we examined the magnitude and time course of effects of FFAs on glucose effectiveness in type 2 diabetes and whether glucose effectiveness can be restored by lowering FFAs. Glucose fluxes ([3-3H]-glucose) were measured during 6-h pancreatic clamp studies, at euglycemia (5 mmol/l glucose, t = 0-240 min), and hyperglycemia (10 mmol/l, t = 240-360 min). We studied 19 poorly controlled subjects with type 2 diabetes (HbA1c 10.9 ± 0.4%, age 50 ± 3 years, BMI 30 ± 2 kg/m2) on at least two occasions with saline (NA- group) or nicotinic acid (NA group) infusions for 3, 6, or 16 h (NA3h, NA6h, and NA16h groups, respectively) to lower FFAs to nondiabetic levels. As a reference group, glucose effectiveness was also assessed in 15 nondiabetic subjects. There was rapid improvement in hepatic glucose effectiveness following only 3 h of NA infusion (NA3h = 31 ± 6% suppression of EGP with hyperglycemia vs. NA- = 8 ± 7%; P < 0.01) and complete restoration of glucose effectiveness after 6 h of NA (NA6h = 41 ± 8% suppression of EGP; P = NS vs. nondiabetic subjects). Importantly, the loss of hepatic glucose effectiveness in type 2 diabetes is completely reversible upon correcting the increased FFA concentrations. A longer duration of FFA lowering may be required to overcome the chronic effects of increased FFAs on hepatic glucose effectiveness.

AB - Impaired effectiveness of glucose to suppress endogenous glucose production (EGP) is an important cause of worsening hyperglycemia in type 2 diabetes. Elevated free fatty acids (FFAs) may impair glucose effectiveness via several mechanisms, including rapid changes in metabolic fluxes and/or more gradual changes in gene expression of key enzymes or other proteins. Thus, we examined the magnitude and time course of effects of FFAs on glucose effectiveness in type 2 diabetes and whether glucose effectiveness can be restored by lowering FFAs. Glucose fluxes ([3-3H]-glucose) were measured during 6-h pancreatic clamp studies, at euglycemia (5 mmol/l glucose, t = 0-240 min), and hyperglycemia (10 mmol/l, t = 240-360 min). We studied 19 poorly controlled subjects with type 2 diabetes (HbA1c 10.9 ± 0.4%, age 50 ± 3 years, BMI 30 ± 2 kg/m2) on at least two occasions with saline (NA- group) or nicotinic acid (NA group) infusions for 3, 6, or 16 h (NA3h, NA6h, and NA16h groups, respectively) to lower FFAs to nondiabetic levels. As a reference group, glucose effectiveness was also assessed in 15 nondiabetic subjects. There was rapid improvement in hepatic glucose effectiveness following only 3 h of NA infusion (NA3h = 31 ± 6% suppression of EGP with hyperglycemia vs. NA- = 8 ± 7%; P < 0.01) and complete restoration of glucose effectiveness after 6 h of NA (NA6h = 41 ± 8% suppression of EGP; P = NS vs. nondiabetic subjects). Importantly, the loss of hepatic glucose effectiveness in type 2 diabetes is completely reversible upon correcting the increased FFA concentrations. A longer duration of FFA lowering may be required to overcome the chronic effects of increased FFAs on hepatic glucose effectiveness.

KW - EGP

KW - Endogenous glucose production

KW - FFA

KW - Free fatty acid

UR - http://www.scopus.com/inward/record.url?scp=33748300622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748300622&partnerID=8YFLogxK

U2 - 10.2337/db05-0988

DO - 10.2337/db05-0988

M3 - Article

C2 - 16731840

AN - SCOPUS:33748300622

VL - 55

SP - 1761

EP - 1768

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 6

ER -